There are 2789 resources available
1410P - Gastric cancer: Data from the AGAMENON-SEOM study
Presenter: Ismael Macias Declara
Session: ePoster Display
1411P - A prospective, multicenter, real-world study of apatinib in the treatment of gastric cancer
Presenter: Jianping Xiong
Session: ePoster Display
Resources:
Abstract
1412P - Palliative stents in a large cohort of advanced gastroesophageal cancers (GOC): Factors associated with long term survival
Presenter: Clare Hannon
Session: ePoster Display
1413P - Antibiotic administration and outcome of patients with advanced gastric cancer receiving programmed death-1 inhibitors or with single-agent chemotherapy
Presenter: Minkyu Jung
Session: ePoster Display
1359TiP - RELATIVITY-104: First-line relatlimab (RELA) + nivolumab (NIVO) with chemotherapy vs nivo with chemotherapy in stage IV or recurrent non-small cell lung cancer (NSCLC): A phase II, randomized, double-blind study
Presenter: Daniel Morgensztern
Session: ePoster Display
1252P - Liquid biopsy to track KRAS G12C mutation at progressive disease in patients with advanced non-small cell lung cancer (NSCLC)
Presenter: Gianluigi De Renzi
Session: ePoster Display
1254P - Efficacy and safety of tepotinib in patients (pts) with advanced age: VISION subgroup analysis of pts with MET exon 14 (METex14) skipping NSCLC
Presenter: Marina Chiara Garassino
Session: ePoster Display
1255P - Health utility with tepotinib in patients (pts) with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC)
Presenter: Niels Reinmuth
Session: ePoster Display
1256P - Capmatinib safety update in MET dysregulated NSCLC from the GEOMETRY mono-1 trial
Presenter: Rebecca Heist
Session: ePoster Display